Literature DB >> 10595640

A new factor Xa inhibitor (lefaxin) from the Haementeria depressa leech.

F Faria1, E M Kelen, C A Sampaio, C Bon, N Duval, A M Chudzinski-Tavassi.   

Abstract

The salivary complex of the leech Haementeria depressa produces potent anticoagulant components. Among them, a protein named lefaxin inhibits factor Xa (FXa). Lefaxin was purified to homogeneity from dissected salivary complexes by gel filtration in Sephadex G-150 followed by two ion exchange chromatography steps in Mono-Q. Inhibition of FXa by lefaxin was demonstrated by the inhibition of its amidolytic activity, measured with chromogenic substrate S-2765 (apparent K(I) of 4 nM), and of its ability to inhibit thrombin generation in the prothrombinase complex (EC50 of 40 nM). Lefaxin has a molecular weight of 30 kDa and an isoelectric point of 5.7. It is made of a polypeptide chain whose N-terminal sequence shows no similarity with that of other FXa inhibitors (antistasin and ghilianten) isolated from leech saliva. On the other hand, the N-terminal sequence of lefaxin presents significant sequence similarity with nitric oxide carrier proteins myohemerythrin from the annelid Nereis diversicolor and prolixin S from the triatoma Rhodnius prolixus. Interestingly, prolixin S also proved to be an anticoagulant protein acting on FXa.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595640

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

Review 1.  New anticoagulant drugs.

Authors:  J I Weitz
Journal:  J Thromb Thrombolysis       Date:  2001-09       Impact factor: 2.300

2.  Characterization of thrombin/factor Xa inhibitors in Rhizoma Chuanxiong through UPLC-MS-based multivariate statistical analysis.

Authors:  Yi-Yao Yang; Zhao-Yu Wu; Fang-Bo Xia; Hao Zhang; Xu Wang; Jian-Li Gao; Feng-Qing Yang; Jian-Bo Wan
Journal:  Chin Med       Date:  2020-08-31       Impact factor: 5.455

3.  LC-MS-based multivariate statistical analysis for the screening of potential thrombin/factor Xa inhibitors from Radix Salvia Miltiorrhiza.

Authors:  Yi-Yao Yang; Zhao-Yu Wu; Hao Zhang; Shi-Jun Yin; Fang-Bo Xia; Qian Zhang; Jian-Bo Wan; Jian-Li Gao; Feng-Qing Yang
Journal:  Chin Med       Date:  2020-04-26       Impact factor: 5.455

Review 4.  Leech therapeutic applications.

Authors:  A M Abdualkader; A M Ghawi; M Alaama; M Awang; A Merzouk
Journal:  Indian J Pharm Sci       Date:  2013-03       Impact factor: 0.975

5.  Novel Cysteine Protease Inhibitor Derived from the Haementeria vizottoi Leech: Recombinant Expression, Purification, and Characterization.

Authors:  Débora do Carmo Linhares; Fernanda Faria; Roberto Tadashi Kodama; Adriane Michele Xavier Prado Amorim; Fernanda Calheta Vieira Portaro; Dilza Trevisan-Silva; Karla Fernanda Ferraz; Ana Marisa Chudzinski-Tavassi
Journal:  Toxins (Basel)       Date:  2021-12-02       Impact factor: 4.546

6.  WPK5, a Novel Kunitz-Type Peptide from the Leech Whitmania pigra Inhibiting Factor XIa, and Its Loop-Replaced Mutant to Improve Potency.

Authors:  Yi-Zheng Zheng; Xiao-Ru Ji; Yun-Yang Liu; Shuai Jiang; Xiang-Ying Yu; Zhi-Ping Jia; Yue Zhao; Jun-Qiao Zhang; Jia-Li Zhang; Yi Kong
Journal:  Biomedicines       Date:  2021-11-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.